Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 4059

OpenAI cofounder and CEO Sam Altman sat down for a wide-ranging interview with us late last week, answering questions about some of his most ambitious personal investments, as well as about the future of OpenAI.

This second clip is focused exclusively on artificial intelligence, including how much of what OpenAI is developing Altman thinks should be regulated, whether he’s worried about the commodification of AI, his thoughts about Alphabet’s reluctance to release its own powerful AI, and worst-and best-case scenarios as we move toward a future where AI is ever-more central to our lives.

There was much to discuss (and he was generous to stay and talk about it).

You can find the first part our sit-down — focused in part on Helion Energy, a nuclear fusion company that has become Altman’s second-biggest project — here: https://youtu.be/57OU18cogJI

Continue reading “StrictlyVC in conversation with Sam Altman, part two (OpenAI)” | >

The inside of a person’s mouth can say a lot about their overall health. Studies have established links between poor oral health and conditions like heart disease, high blood pressure and pneumonia. Now, a new study shows there’s a connection to the brain. Researchers in the U.K. found certain bacteria in the mouth may cause deadly brain abscesses.

Read more | >

This shapeshifting controls the biological processes of living things—for example, opening the protein tunnels dotted along neurons or driving cancerous growth. But it also makes understanding protein behavior and developing drugs that interact with proteins a challenge.

While recent AI breakthroughs in the prediction (and even generation) of protein structures are a huge advance 50 years in the making, they still only offer snapshots of proteins. To capture whole biological processes—and identify which lead to diseases—we need predictions of protein structures in multiple “poses” and, more importantly, how each of these poses changes a cell’s inner functions. And if we’re to rely on AI to solve the challenge, we need more data.

Thanks to a new protein atlas published this month in Nature, we now have a great start.

Read more | >

Israeli scientists are aiming to produce the world’s first preventative drug designed to stop tumors causing secondary cancer, and say the active ingredient has shown more than 90 percent effectiveness in mice.

The Bar Ilan University research team produced a peptide — a chain of amino acids — made to stop cancer cells from entering the blood and therefore halting them from moving around the body.

They have published peer-reviewed research showing that it successfully prevented metastasis in mice, meaning it prevented the spread of diseased cells that can cause secondary cancer.

Read more | >